TRiNDS Team Spotlight:  Linda Johnson, Clinical Evaluations Manager

October 21, 2020

TRiNDS Team Spotlight:  Linda Johnson, Clinical Evaluations Manager

All of us at TRiNDS come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to introduce Linda Johnson, Clinical Evaluations Manager. We sat down with Linda to learn more about her and her work.

How did you come to work in clinical research?

Linda: Most people don’t know that clinical research was one of my first jobs when I graduated from University of California San Francisco in 1981.  Research fits perfectly with my analytical and detail-oriented brain.  Fast forward to 2003, when University of California Davis needed a Physical Therapist for the Cooperative International Neuromuscular Research Group (CINRG) prednisone trial.  I was available and interested and I fell in love with the participants and their families.

What does your typical day look like at TRiNDS?

Linda: As a contractor at TRiNDS, my hours are flexible.  I review and address emails daily.  I work with the site Clinical Evaluators throughout a study to ensure they follow protocols and to answer their questions as needed.  I am busiest when I review data since I look at every data point for each of the outcome measure for each participant visit.

What are you most excited about for the future of neuromuscular research?

Linda: Neuromuscular research is now addressing the needs of participants with all levels of disease progression and function.  This opens the possibility of not only improving disease treatments but exploring functional therapy interventions to improve quality of life.   Technology is advancing rapidly and needs to be applied to these populations.

TRiNDS offers expert specialized study measurements services to sponsors conducting neuromuscular and rare disease research. We customize our services to each project to meet its unique needs. Contact us for more information about how TRiNDS can help your project succeed.